Motley Fool Money cover image

Nobody Told Us This Was M&A Week

Motley Fool Money

00:00

R&D Economics and FDA Risk

Lou and Matt discuss drug trial success rates, pharma R&D costs, and regulatory uncertainty for investors.

Play episode from 11:44
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app